The research compound in Zepbound®
Zepbound® is a chronic weight management medicine from Eli Lilly and Company. Its active compound is Tirzepatide — which is what this catalogue supplies, as a research material.
This is not Zepbound®, and NOVALYTE LABS has no affiliation with Eli Lilly and Company. We supply the compound Tirzepatide for laboratory research only — not for human consumption, diagnostic, therapeutic or veterinary use. Zepbound® is a trademark of Eli Lilly and Company, referenced here only to identify the compound.
Zepbound is Eli Lilly’s brand for tirzepatide in weight management. The active compound is identical to that in Mounjaro; the brands differ by approved indication rather than by molecule.
Tirzepatide activates the GIP and GLP-1 receptors simultaneously, combining two incretin pathways in one peptide.
The compound is listed here as a research material with batch documentation, not as the branded medicine.
Tirzepatide in this catalogue
2.5mg × 4 pens
How Tirzepatide is supplied here
Everything below describes the research material in this catalogue, not the medicine. Tirzepatide is stocked in 4 presentations, so the figures below are for the base one.
| Compound | Tirzepatide |
|---|---|
| Presentation | 2.5mg × 4 pens |
| Dosage options | 2.5mg × 4 pens · 5mg × 4 pens · 10mg × 4 pens · 15mg × 4 pens |
| Research category | Metabolic Research |
| Batch COA | Certificate supplied with order |
| Availability | In stock |
| Intended use | Laboratory research only — not for human or veterinary use |
Common questions
What is the active compound in Zepbound?
Tirzepatide. Zepbound is a registered trademark of Eli Lilly and Company, approved for chronic weight management.
Is this Zepbound?
No. NOVALYTE LABS supplies Tirzepatide as a research material with batch documentation. It is not Zepbound, it is not a medicine, it is not supplied for human use, and there is no affiliation with Eli Lilly and Company.
Why is Tirzepatide sold under more than one brand?
Because a brand is tied to an approved indication rather than to the molecule. Tirzepatide is marketed as Zepbound and also as Mounjaro — same compound, different approvals.
Other brands using Tirzepatide
The same compound is marketed under more than one brand, usually because each brand carries a different approved indication.